COHR

Q: What is the price of Coherent (COHR) today?

A cotação de Coherent (COHR) hoje está em $ 374.01, com uma variação de The stock began the year trading around $ 184.57 and is currently priced at $ 374.01. negociando na casa dos $ 184.57 e hoje está em $ 374.01. Acompanhe o and track broader market trends directly on the platform.

Q: When does Coherent (COHR) pay dividends?

Coherent (COHR) did not pay dividends over the past year.

Q: Is Coherent (COHR) a good investment?

Atualmente, Coherent (COHR) está cotada a $ 374.01, com um P/L de 135.86, This represents a 19,715% premium compared to its historical average P/E. uma variação de 380.92 em sua cotação e distribuiu $ 0.00 em dividendos, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 380.92%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Coherent Inc.

Price

$ 374.01

return (12m)

380.92%

p/e

135.86

p/bv

5.78

DIVIDEND YIELD

0.00%

COHR price

COHR

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment COHR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

21.63%

3 months

67.20%

1 year

380.92%

2 years

596.61%

5 years

487.42%

10 years

1,814.07%

Fundamentals COHR

review the fundamentals of Coherent shares

P/E

135.86

Sector: -1.72 Industry: 1.11

P/S (PSR)

9.65

Sector: 1.94 Industry: 2.48

P/BV

5.78

Sector: 2.16 Industry: 2.27

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

2.71%

Sector: -25.77% Industry: -24.38%

ROE

4.26%

Sector: -29.19% Industry: -31.44%

ROIC

6.93%

Sector: -428.36% Industry: -81.70%

NET MARGIN

7.10%

Sector: -27.84% Industry: -31.09%

GROSS MARGIN

36.78%

Sector: 45.02% Industry: 51.18%

OPERATING MARGIN

11.24%

Sector: -22.92% Industry: -27.87%

EV/EBITDA

58.37

Sector: -0.31 Industry: 1.15

EV/EBIT

89.71

Sector: -1.90 Industry: -0.08

PRICE-TO-ASSETS

3.68

Sector: 1.16 Industry: 1.21

BVPS

57.98

Sector: 3.78 Industry: 4.85

EPS

2.47

Sector: -0.82 Industry: -0.70

EQUITY-TO-ASSETS RATIO

0.64

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.36

Sector: 0.47 Industry: 0.50

CAGR REVENUE 5 YEARS

15.64%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

8.95%

Sector: - Industry: -

FAIR VALUE OF Coherent ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 374.01

Fair Value

$ 0.00

Upside/Downside Return potential.

-84.82%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals COHR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	33.59	27.21	81.01%	0.66%	$ 848.86 B	34.98%
ISRG	53.63	9.08	16.93%	0.00%	$ 159.77 B	28.15%
TMO	25.26	3.32	13.15%	0.38%	$ 172.98 B	15.15%
SNY	11.59	1.26	10.86%	5.11%	$ 105.72 B	18.68%
NVS	20.60	7.16	34.77%	2.12%	$ 278.77 B	23.92%
ABT	25.14	0.00	0.00%	2.64%	$ 157.79 B	13.91%
MDT	21.18	1.99	9.38%	3.73%	$ 97.70 B	13.00%
GSK	12.93	4.37	33.77%	3.48%	$ 101.42 B	17.79%
CVS	39.31	1.48	3.78%	2.94%	$ 115.27 B	0.72%
BSX	22.46	0.00	0.00%	0.00%	$ 80.09 B	17.29%
TMDX	13.42	4.67	34.80%	0.00%	$ 2.31 B	27.04%
HCA	14.35	-32.73	-228.14%	0.68%	$ 97.48 B	8.89%
IDXX	40.91	28.80	70.38%	0.00%	$ 44.81 B	24.63%
RMD	19.73	4.62	23.41%	1.13%	$ 29.98 B	27.44%
DHR	32.85	2.29	6.97%	0.79%	$ 121.18 B	14.89%
INMD	10.09	1.33	13.18%	0.00%	$ 879.48 M	23.27%
PHG	22.93	1.96	8.56%	3.26%	$ 25.90 B	5.50%
SYK	32.76	4.76	14.52%	1.21%	$ 109.34 B	13.21%
FMS	11.00	0.74	6.71%	3.57%	$ 12.12 B	4.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

COHR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	12/17/2012	12/27/2012	1,00000000

ABOUT Coherent

Coherent Inc.

Average Investor10 user rating

4.0 (10 people)

United States

60 years

Founded: 1966

1990

Time since IPO - 36 years

4.875

Employees

Coherent Inc. (United States) is listed on the Nasdaq and has a market capitalization of $63.70 Billions, with shareholders equity totaling $11.02 Billions.

The company employs approximately 4.875 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Coherent Inc. reported $6.60 Billions in revenue, generating net income of $468.87 Millions.

Key financial metrics include a P/E ratio of 135.86, a price-to-book (P/B) ratio of 5.78, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker COHR.

Market cap

$ 63.70 Billions

Net worth

$ 11.02 Billions

$ 11,015,690,000.00

Assets

$ 17.29 Billions

$ 17,286,700,000.00

Total Shares Outstanding

190.00 Millions

190,000,000

Average Daily Trading Volume

$ 7.93 Millions

$ 7,933,444.00

Sector

Health

Industry

Medical Supplies and Equipment

COHR

revenue by Business Segment Coherent

Revenue by Region Coherent

COHR revenue and profits

Financial Results COHR

DRAG THE FRAME TO SEE MORE DATA

COHR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 95.15 63,02% (12M)

P/E

39.31

2.94%

ROE

3.78%

P/BV

1.48

CI - Cigna

$ 298.49 1,52% (12M)

P/E

10.52

2.11%

ROE

16.97%

P/BV

1.79

CNC - Centene

$ 59.31 0,58% (12M)

P/E

-4.27

0.00%

ROE

-29.93%

P/BV

1.28

HUM - Humana

$ 295.35 31,50% (12M)

P/E

29.20

1.29%

ROE

6.06%

P/BV

1.77

LLY - Eli Lilly

$ 989.87 39,60% (12M)

P/E

33.59

0.66%

ROE

81.01%

P/BV

27.21

HCA - HCA Healthcare

$ 429.69 17,73% (12M)

P/E

14.35

0.68%

ROE

-228.14%

P/BV

-32.73

NVS - Novartis

$ 148.16 41,40% (12M)

P/E

20.60

2.12%

ROE

34.77%

P/BV

7.16